Argonaut Manufacturing Services announces launch of aseptic drug product manufacturing servicesHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Argonaut Manufacturing Services announces launch of aseptic drug product manufacturing servicesPR NewswireJanuary 7, 2020ReblogShareTweetShareNew introduction supports industry shortage of high-yield filling service providersCARLSBAD, Calif., Jan. 7, 2020 /PRNewswire/ -- Argonaut Manufacturing Services, a premier contract development and manufacturing organization (CDMO) for biopharma, has announced the recent launch of their state-of-the-art aseptic vial filling services. Designed to maximize yield of expensive biologics and other high value drug substances, the custom Bausch + Ströbel VarioSys® line is the most advanced of its kind.Argonaut worked closely with the Bausch + Ströbel engineering team to design an optimal filling line for biologics. "As drug substance values continue to rise, we saw a need in the market for fill/finish service providers to adapt. Our line incorporates technologies designed to maximize yield and minimize risk, in order to safeguard every drop of API," said Chris Duffy, COO of Argonaut. Key line features include robotics, isolator technology, minimal hold up volume, and in-line non-destructive 100% weight checks.Eric Blair, CCO of Argonaut commented: "We are dedicated to supporting our clients in clinical trials and beyond, and we are honored to have our first clients developing the most innovative therapies.  The ADVANCEDFill technology our line features is ideal in the areas of rare disease, orphan drugs, and other small-batch biologics applications. Personalized medicine is driving an industry need for our services, as we have the ability to provide the small batch throughput and near zero-loss yield needed for precious drug substance."The new introduction builds upon Argonaut's existing strengths and capabilities. "I'm incredibly proud of our team of established industry leaders. Argonaut has designed and built our drug product manufacturing services to meet the demanding requirements of the world's best biopharma companies," said Wayne Woodard, CEO of Argonaut. "Our advanced capabilities match the needs for drug product manufacturing today and for decades to come."With the announcement of the launch, Argonaut will begin serving clinical phase customers in Q1 2020.For more information, please visit https://www.argonautms.com/drug-product-manufacturing/.About Argonaut Manufacturing ServicesArgonaut Manufacturing Services is an FDA-registered cGMP contract manufacturing organization dedicated to providing custom manufacturing and supply chain solutions for biopharmaceutical companies worldwide. Argonaut features state-of-the-art automated aseptic fill-finish equipment for sterile injectable drugs. Projects are supported by a full analytical quality control service offering and global shipping logistics. Argonaut provides a wide range of flexible solutions for diverse outsourcing needs. Contact888-834-8892info@argonautms.com www.argonautms.com Argonaut Manufacturing Services LogoMoreCisionMoreView original content to download multimedia:http://www.prnewswire.com/news-releases/argonaut-manufacturing-services-announces-launch-of-aseptic-drug-product-manufacturing-services-300982119.htmlSOURCE Argonaut Manufacturing ServicesReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextCoronavirus (COVID-19) Supply Chain UpdatePR NewswireChina Set to Release Biggest Insight into Virus-Hit EconomyBloombergAtlanta manufacturer buys consumer packaging business for $85MAmerican City Business JournalsCoca-Cola: Can coronavirus affect your Diet Coke habit?USA TODAYCoronavirus is drying up the supply chains of Southeast Asia’s factoriesQuartzBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoAsian markets continue to slump, as Nikkei enters correction territoryMarketWatch'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video